AUPH
Aurinia Pharmaceuticals Inc.
Recent 8-K filings for AUPH
Each filing is summarized by an LLM — headline, three bullets, event type. The source document on EDGAR is one click away. See methodology.
-
May 11, 2026 13:20 UTC m_and_a item 2.01item 9.01
Aurinia completes acquisition of Kezar Life Sciences for $6.955/share plus CVR
source · AUPH on sec.gov